BACKGROUND AND OBJECTIVES: The value of liver resection for metastases from @entity0 is still controversial. This study was conducted to clarify safety and effectiveness of hepatectomy in this conditions and to identify selection criteria for @entity1 suitable for liver resection. METHODS: From January 1988 to December 2006, 39 @entity1 underwent liver resection for metastases from @entity0 . The outcome of these 39 @entity1 was retrospectively reviewed using a prospective database. Prognostic factors for @entity1 survival were determined by univariate and multivariate analysis. RESULTS: None of the @entity1 died perioperatively and the morbidity rate was 13% (n = 5). The overall 1-, 3-, and 5-year survival rates were 77%, 50%, and 42%, respectively. In the univariate analysis, metastatic manifestation prior to hepatectomy, vascular invasion and resection margin revealed statistically significant influence on survival. The multivariate analysis identified only resection margin as an independent prognostic factor for survival. CONCLUSIONS: Liver resection should be considered in the multimodal treatment approach of @entity1 with metastatic @entity0 . Hepatic resection can be performed with low risk and offers a chance of long-term survival. Achievement of a curative resection and less important absence of previous metastatic manifestation represent suitable criteria to select @entity1 for liver resection.

Liver resection for metastases from XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast cancer']
@entity0 :: (MESH:D001943,Disease) :: ['breast cancer']
